INTRODUCTION
Extended spectrum beta-lactamase (ESBL) is an enzyme that hydrolyzes the beta-lactam ring in antibiotics and readily inactivates firstline drugs such as cephalosporins, penicillins and monobactams [1] . With the limited availability of alternative antibiotics and the increase in antibiotic resistance worldwide, ESBLs-producing Enterobacteriaceae is a serious threat to current beta-lactam therapy [2] . In the United States, for example, a survey of the intensive care units of 400 hospitals between 1990 and 1993 recorded an increase from 3.6 to 14.4 % in ESBLproducing strains of Klebsiella spp [3] . In Pakistan, the prevelance of ESBLs-producing bacteria among nosocomial isolates is as high as 48 % [4] . Moreover, before the 1990s, K. pneumoniae isolates typically produced a single beta-lactamase [5] but today, these bacteria produce three to six beta-lactamases [6] .
The use of natural products, such as medicinal plants [7] , as therapy against infectious diseases, is an age-long practice, especially in developing countries. Acacia is an important plant genera that is commonly used in a variety of infections. It is widely distributed in Asia, Australia and America and its efficacy has been demonstrated in the treatment of gonorrhoea, leucorrhoea, diarrhoea, dysentery and wounds [8] . The objective of the present study is to investigate the antibacterial properties of crude methanol lysates of Acacia pods against multidrug resistant ESBLs and MRSA in vitro and also to determine whether the lysates had any cytotoxic effects on human cells.
EXPERIMENTAL Plant material
Acacia nilotica Lam (Mimosaceae) was obtained from Dr M Faisal, Botany Department, University. of Punjab, Pakistan. For future reference, a voucher specimen was deposited in the Herbarium of Punjab University with voucher specimen no. 69306.
Preparation of Acacia nilotica lysate
Ten grams of shade-dried Acacia nilotica pods were ground and soaked in 100 mL of methanol (100 %). Extraction was performed in a water bath at 25 °C for one week with continuous shaking using Cole_Parmer Orbital shaker. The extract was filtered, concentrated at 40 °C under reduced pressure, dried in a freeze-dryer and stored at 4 °C pending further use. The extract was re-suspended in water at a concentration of 100 mg/ml prior to use [9] .
Bacterial isolates
Clinical specimens (mostly urine, blood, sputum, foley tip and wound swabs) were obtained from Citilab and Research Center, Lahore. The specimens were processed according to standard operating procedures [10] . The clinical samples were plated on blood agar plates. Environmental samples (from sewage, soil and standing water) were collected from hospital surroundings. All the bacterial isolates were characterized by colony morphology and biochemical testing. Escherichia coli and Klebsiella spp were selected and their identity confirmed using 20 E API (BioMerieux). Klebsiella pneumoniae ATCC 700603 [11] and E. coli ATCC 25922 [12] were used as reference strains.
The bacterial isolates were tested for the presence of beta-lactamases using doubledisk synergism (DDS) test method which entailed the application of cefpodoxime, ceftazidime, aztreonam, cefotaxime or ceftriaxone [1, 2, 13] . To further confirm betalactamase properties, Epsilometer test was carried [2] . Briefly, drug-impregnated AB Biodisk strips were used (Solna, Sweden), one end of which contains a gradient of ceftazidime (MIC test range, 0.5 to 32 µg/ml) and on the opposite end, a gradient of ceftazidime plus a constant concentration of clavulanate (4 µg /ml). The MICs of both ends are interpreted as the point of intersection of the inhibition ellipse with the E-test strip edge [2] . E. coli K1 [14] and MRSA [15] were used in cytotoxicity assay. All the selected strains were preserved in glycerol stocks [16] .
Antibiotic susceptibility testing
Antibiotic evaluation test was performed on Muller Hinton agar using Kirby bauer method as per Clinical Laboratory Standards Institute [10] . Briefly, antibiotic disks containing amikacin 30 µg, ampicillin 10 µg , amoxicillinclavulanic acid (20 µg/10 µg) 30 µg, carbencilin 100 µg, cephredine 30 µg, cefaperazone 75 µg, ciprofloxacin 5 µg, gentamicin 10 µg, nitrofurontoin 300 µg, imepenum10 µg, meropenum10 µg, norfloxacin 10 µg, cotrimexazole 25 µg, ceftizoxime 30 µg, cefotaxime 30 µg, cefoxitin 30 µg, cetazidime 30 µg, ceftriaxone 30 µg, cefixime 5 µg, aztreonam 10 µg, and pipracilin-tazobactam 100/10 µg [17] were tested. The results are listed in Table 1 .
Bactericidal assays
A 100 µl aliquot of the crude extract was incubated with approx. 10 6 bacterial cells (E. coli, Klebsiella, K1 or MRSA) suspended in 10 µl. Tubes containing lysate alone, or phosphate buffer saline (PBS) alone were used as controls. The tubes were incubated for 2 h at 37 °C, and bacterial counts determined by making serial dilution and plating on nutrient agar plates as previously described [18] . The number of colony-forming units (cfu was determined after an overnight incubation at 37 °C. Bactericidal effect (BE) was determined as in Eq 1.
BE (%) = (100 -cfu in lysate)/(total bacterial cfu) x 100 …………………………… (1)
Total bacterial cfu were calculated by incubating bacteria alone without the lysate. In some experiments, different concentration of lysate (0.01, 0.05, 0.1, 0.5, 1, 2.5, 5, and 10 mg/ml) were used for the bactericidal assay. In all assays, the total volume was adjusted to 100 µl with PBS and bactericidal effect determined as above. To determine the nature of antimicrobial compound(s), the lysate was heated at 100 °C for 10 min in the presence or absence of sodium dodecyl sulfate (SDS), followed by bactericidal assay.
Cytotoxicity assay
Human brain microvascular endothelial cells (HBMEC) were routinely grown in RPMI-1640 containing 10 % foetal bovine serum, 10 % NuSerum, 2mM glutamine, 1 mM pyruvate, penicillin (100 U/ml), streptomycin (100 U/ml), non-essential amino acids and vitamins (Invitrogen, Paisley, UK), as previously described [14] .
To determine whether the lysate exhibits toxic effect on HBMEC, cytotoxicity assay was performed, as previously described [19] . Briefly, HBMEC grown to confluency in 24-well plates were incubated with various volumes of lysates including 25, 50, 100, 200 µl and the final volumes adjusted to 500 µl with RPMI-1640. The plates were incubated for 24 h at 37 °C in a 5 % CO 2 incubator. Following incubation, the supernatant of each well was collected and cell death determined using a cytotoxicity detection kit (Roche Applied Science, Lewes, UK). This assay is based on measuring lactate dehydrogenase (LDH) release. Lactate dehydrogenase (LDH) is a soluble cytosolic enzyme, found in all cells and is released into the culture medium only by damaged cells. Thus, the release of LDH is considered as an estimate of cell death. There are two steps of reaction which determine LDH. In the first step, the reaction involves reduction of nicotinamide adenine dinucleotide (NAD) + to nicotinamide adenine dinucleotide (reduced form, NADH) by oxidation of lactate to pyruvate. In the second step, the catalysed diaphorase, transfers 2 hydrogen from NADH + + H + to the terazolium salt (INT), which is subsequently reduced to formazan. Formazan dyes are artificial chromogenic substrates for dehydrogenases and reductases; they are water soluble and show a broad absorption maximum at about 500 nm while the tetraxolium salt (INT) shows no significant absorption at this wavelength. Thus, an increase in the amount of plasma membrane-damaged cells results in an increase of LDH enzyme activity in the culture supernatant. Cytotoxicity (Ct) was determined as in Eq 2.
Ct (%) = (Test value -control value)/(total LDH release -control value) x 100 ….. (2)
Control values were obtained from HBMEC incubated alone and total LDH release was measured from HBMEC-treated with 5 % Triton X-100 for 1 h at 37 °C. Triton X-100 is a detergent that permeabilizes eukaryotic cells and results in HBMEC damage.
Fast Protein Liquid Chromatography (FPLC)
FPLC was performed on the lysate using a Bio-Rad Biologic Workstation system. Sterile water was used as the solvent at a flow rate of 0.5 ml/min with fractions collected into sterile microcentrifuge tubes. A size exclusion column (3 kDa -75 kDa) packed with Sephadex and agarose beads (GE Healthcare) was used in order to fractionate the crude lysate on the basis of molecular weight. Thereafter, the different fractions were screened for antibacterial activity (see Fig 1) 
Statistical analysis
Statistical analysis was carried out using SPSS 17 software. Standard error mean (SEM) was calculated based on three independent experiments. Chi square test was used to calculate statistical significance. Other data are presented as percentages.
RESULTS

Antibacterial activity of Acacia nilotica lysate
The results of antibacterial activity of the A. nilotica lysates are listed in Table 1 . The findings revealed that aliquots of 100 µl lysate (equivalent to10 mg of A. nilotica lysates) exhibited > 99 % bactericidal activity against MRSA (see Table 1 ). At 10 mg/ml concentration, the extract exhibited > 80 % bactericidal activity against all the clinical isolates of E. coli, but only 52% against E. coli isolated from sewage (Table 1) . A. nilotica lysates exhibited > 90 % bactericidal activity against all K. pneumonia isolates at a concentration of 10 mg/ml except K. pneumonia folly tip isolate against which it showed 42 % ( Table 1 ). The solvent alone had no effect on the viability of any of the bacterial isolates (data not shown).
Effect of denaturing conditions on the bactericidal activity of A. nilotica lysates
The findings revealed that heating the A. nilotica lysates at 100 °C for 10 min had no effect on its bactericidal properties (Table 2) . A concentration of 1 mg/ml exhibited > 90 % bactericidal activity; boiling exhibited a similar bactericidal activity (Table 2) . Similarly, lysates incubated with 1 % sodium dodecyl sulphate (SDS) and treated at 100 °C for 10 min exhibited > 85 % bactericidal activity, indicating that SDS had no effect lysate activity. The solvent alone had no effect on the viability of any of the bacterial isolates (Table 2) .
Antibacterial activity of FPLC-derived fractions of A. nilotica lysate
The results of the use of Fast protein liquid chromatography (FPLC) to characterize and separate fractions of A. nilotica lysate and their antibacterial activities are shown in Fig  1. FPLC fractionation revealed the presence of 8 distinct peaks which showed bacteriocidal activity ranging from 50 to 93 %. This suggests the presence of multiple antibacterial substances molecular weight < 10 kDa. When the FPLC fractions were tested on HBMEC in order to assess their cytotoxicity (LDH release), cytotoxicity ranged 
DISCUSSION
The presence of antimicrobial compounds in plants is a well known fact and they are ancient weapons in the defence against infection. Antimicrobials destroy or inhibit the growth of microbes such as bacteria, viruses, fungi or protozoa and more than 50% of the reported antimicrobial substances are derived from plants [20] . A previous study has shown that the stem, leaves and roots of Acacia are commonly used in the traditional therapy of various diseases [8] .
At 10 mg/ml concentration, A. nilotica lysates exhibited > 95 % antimicrobial activity against all the bacteria tested including neuropathogenic E. coli K1, MRSA, and K. pneumoniae. This is remarkable as lysates demonstrated such potent bactericidal activity against bacterial isolates where several well-known antibiotics failed. It is also interesting that heat treatment of the lysates at 100 °C did not reduce potency of A. nilotica lysates.
FPLC is popular for separation of different compounds in plant extracts [21] . FPLC data suggest that there is more than one compound present in the lysates. The fact that the lysates exhibited potent bactericidal activity against both Gram-negative (neuropathogenic E. coli and K. pneumonia) as well as Gram-positive bacteria (MRSA) is an indication that the putative target(s) was conserved in the bacteria tested. Such broadspectrum antibacterial activity will have tremendous potential in the treatment of bacterial infections. Furthermore, the lysates had limited cytotoxic effect on HBMEC, suggesting that putative target(s) for the active component(s) are absent in eukaryotes.
The present work, which is preliminary in this regard, suggests that the lysates interferred with important structural component of the bacterial membranes, thus leading to defective membranes, and hence increased permeability and leakage of ions from the cell. However, the precise identification of the compounds, their identity and mode of action are yet to be elucidated and are expected to be the subject of future studies. Further studies will need to be performed using individual FPLC fractions against a range of bacteria, protists and fungi in order to obtain a more detailed profile of this promising antibacterial material.
CONCLUSION
The results of this study indicate that the methanol lysate of Acacia nilotica pods contains active compounds capable of killing a range of bacteria types, including MRSA, neuropathogenic E. coli K1, as well as betalactamase positive E. coli and Klebsiella spp. Future work on this plant material should include identification of the nature of its constituent compounds, such as the chemical structure and properties, as well as its mode of action.
